Industry › Healthcare & Pharm
Press Releases
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
China Medical System Holdings Ltd.
Sep 24, 2024 21:00 HKT/SGT
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Ripple Therapeutics
Sep 17, 2024 20:30 HKT/SGT
Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner
Cordlife Group Limited
Sep 17, 2024 13:30 HKT/SGT
Femto Technologies Regains Compliance With Nasdaq Minimum Bid Price Requirement
Femto Technologies Inc
Sep 12, 2024 21:00 HKT/SGT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Sep 11, 2024 12:00 HKT/SGT
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
HighTide Therapeutics Inc.
Sep 11, 2024 11:51 HKT/SGT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Sep 11, 2024 11:34 HKT/SGT
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱（HTD1801）在T2DM中的兩項事後分析
HighTide Therapeutics Inc.
Sep 11, 2024 11:16 HKT/SGT
AI Innovative Award of the 2025 CES Competition to Include Femto Flagship Product
Femto Technologies Inc
Sep 05, 2024 20:45 HKT/SGT
Femto Partners With FDA-Registered Manufacturer to Launch Flagship AI-Driven FemTech Product's Pods
Femto Technologies Inc
Sep 04, 2024 20:45 HKT/SGT